Renovis Surgical Technologies Inc. 04.01.16
Redlands, Calif.-based Renovis Surgical Technologies Inc. has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market the Tesera SC—porous titanium cervical interbody fusion system.
Tesera SC is a porous, titanium, standalone cervical interbody fusion system featuring a three-screw design and a locking cover plate to prevent screw backout. Implants are available in two lordotic angles with varying heights and footprints for proper intervertebral height restoration, along with advanced instrumentation designed to reduce operative steps.
All Tesera implants use additive manufacturing and a patent-pending design to create a highly porous surface structure that allows for bone ingrowth to the implant surfaces, maximizing strength, stability and biologic fixation.
This is the fourth product group featuring the Tesera porous titanium structure for which Renovis Surgical has received FDA clearance; the Tesera SA system for standalone anterior spinal fusion was cleared by the FDA in September of 2013, the Tesera Acetabular system for adult reconstruction was cleared in April 2014, and the Tesera posterior lumbar interbody family was cleared in February last year.
Renovis makes orthopedic, spine, and trauma implants.
Tesera SC is a porous, titanium, standalone cervical interbody fusion system featuring a three-screw design and a locking cover plate to prevent screw backout. Implants are available in two lordotic angles with varying heights and footprints for proper intervertebral height restoration, along with advanced instrumentation designed to reduce operative steps.
All Tesera implants use additive manufacturing and a patent-pending design to create a highly porous surface structure that allows for bone ingrowth to the implant surfaces, maximizing strength, stability and biologic fixation.
This is the fourth product group featuring the Tesera porous titanium structure for which Renovis Surgical has received FDA clearance; the Tesera SA system for standalone anterior spinal fusion was cleared by the FDA in September of 2013, the Tesera Acetabular system for adult reconstruction was cleared in April 2014, and the Tesera posterior lumbar interbody family was cleared in February last year.
Renovis makes orthopedic, spine, and trauma implants.